Compare Cassava Sciences Inc (FLNA) vs iShares iBoxx $ Inv Grade Corporate Bond ETF (LQD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs iShares iBoxx $ Inv Grade Corporate Bond ETF — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while iShares iBoxx $ Inv Grade Corporate Bond ETF trades at $107.45. Which is the better fit depends on your goals.
| FLNA | LQD | |
|---|---|---|
Market Cap | $53.14M | — |
Sector | Health | — |
52-Week High | $4.64 | $112.91 |
52-Week Low | $1.09 | $106.96 |
Enterprise Value | -$33.43M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
LQD trades at $107.335, up 0.12% on the day, with a bearish technical signal driven by moving averages. The ETF shows oversold RSI readings below 30, indicating potential for a near-term bounce. Recent dividends include $0.42 paid in May 2026, with fixed income ETFs gaining investor attention amid economic uncertainty.
Outlook remains cautious due to bearish technicals and interest rate sensitivity. Opportunities exist for income-focused investors via dividends, but risks include Fed policy shifts and inflation pressures. Bond ETF flows are strong, yet narrowing market breadth caps conviction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About iShares iBoxx $ Inv Grade Corporate Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index that the advisor believes will help the fund track the underlying index. The underlying index is designed to provide a broad representation of the US dollar-denominated liquid investment-grade corporate bond market.
Read more on LQD →
